RxDoctor Payments DataLook up a doctor →

Durwin Walker, MD

Family Medicine · Denham Springs, LANPI 1316985898

Payments from drug & device makers

$16,252in general payments, 2019–2025

Across 924 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$2K
  • Lilly USA, LLC$2K
  • AbbVie$1K
  • AstraZeneca$1K
  • Boehringer Ingelheim$1K
  • Pfizer$1K
  • plus $7K from 49 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK139$2,369
Lilly USA, LLC126$1,985
AbbVie(2 entities)84$1,497
AstraZeneca44$1,351
Boehringer Ingelheim75$1,248
Pfizer66$1,160
Novo Nordisk62$958
Takeda Pharmaceuticals U.S.A., Inc.43$658
Johnson & Johnson39$568
Astellas Pharma US Inc32$477
Bayer10$314
Axsome Therapeutics, Inc.9$298
Jazz Pharmaceuticals Inc.13$281
Sanofi-aventis U.S. LLC19$258
Novartis17$251
Amarin Pharma, Inc.15$223
Amgen11$191
Merck11$189
Abbott6$179
Lundbeck LLC7$143
Paratek Pharmaceuticals, Inc.11$137
Eisai Inc.7$135
Teva Pharmaceuticals USA, Inc.8$123
Genentech USA, Inc.7$121
Esperion Therapeutics, Inc.2$108
Corium, LLC7$104
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$74
Ironshore Pharmaceuticals Inc.3$71
Adlon Therapeutics L.p.4$58
Neurocrine Biosciences, Inc.2$55
Biohaven Pharmaceuticals, Inc.3$51
Exact Sciences3$48
Vertex2$46
E.r. Squibb & Sons, L.L.C.3$46
Avanir Pharmaceuticals, Inc.2$39
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$37
Antares Pharma, Inc.2$34
Supernus Pharmaceuticals, Inc.2$34
Otsuka Pharmaceutical Development & Commercialization, Inc.1$33
Otsuka America Pharmaceutical, Inc.2$29
Vanda Pharmaceuticals Inc.1$27
Shire North American Group Inc2$25
Phathom Pharmaceuticals, Inc.2$25
Sanofi1$24
Sanofi Pasteur Inc.1$20
Biohaven Pharmaceutical Holding Company Ltd.1$19
Xeris Pharmaceuticals, Inc.1$18
Ardelyx, Inc.1$17
Sunovion Pharmaceuticals Inc.1$16
Tris Pharma Inc1$15
Bausch Health US, LLC1$15
Inogen, Inc.1$14
Boston Scientific1$14
Dexcom, Inc.1$13
Sumitomo Pharma America, Inc.1$9

How this compares

$16,252 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024
$88,449
Medicare patients
155
Services billed
1,481

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Denham Springs

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →